复发性肌肉内血瘤显示中度先天性XIII因子缺乏症
Nada Ben Halima1, Salma Riahi2, Ines Mazlout3
1Laboratory of Hematology and Blood Bank/Laboratory of Parasitology, Sahloul Hospital, Faculty of Medicine of Sousse, University of Sousse, Sousse, TUN.
Cureus
|December 2, 2025
概括
本案例报告强调了在术后出血后对中度XIII因子缺乏症的延迟诊断. 早期识别这种罕见的出血障碍对于有效的管理和更好的患者结果至关重要.
科学领域:
- 血液学 血液学 血液学
- 凝血障碍 凝血障碍 凝血障碍
- 罕见疾病 罕见疾病
背景情况:
- 先天性XIII因子缺乏症是一种罕见的出血障碍.
- 严重缺乏症可能导致危及生命的出血.
- 轻度/中度缺乏通常会出现延迟或引起的出血.
研究的目的:
- 报告一个中度程度的XIII因子缺乏症的延迟诊断病例.
- 审查轻度/中度XIII因子缺乏症的症状.
- 讨论当前的治疗选择和早期诊断的重要性.
主要方法:
- 案例报告的呈现方式 案例报告的呈现方式
- 关于症状和治疗方法的文献综述
主要成果:
- 一名中度XIII因子缺乏症的患者在术后出血后被诊断为晚期出血.
- 检查了轻度和中度XIII因子缺乏症的症状.
- 审查了当前的治疗策略.
结论:
- 早期诊断XIII因子缺乏对于最佳的患者管理至关重要.
- 及时识别可以改善患者在罕见的出血障碍的治疗结果.
- 了解缺陷模式有助于及时进行干预.
相关概念视频
01:24Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
01:29Venous Thrombosis III: Interprofessional Care
265
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
265
01:20Extrinsic and Intrinsic Pathways of Hemostasis
11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
01:16Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
275
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
275